Q4 2018 Bayer AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's investor and analyst conference call on the full year and fourth quarter 2018 results. (Operator Instructions) And I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead, sir.
Emma, thank you very much. Good afternoon, and thanks for joining us today. I would like to welcome all of you for our fourth quarter and full year 2018 conference call. With me on the call today are Werner Baumann, our CEO; Wolfgang Nickl, our CFO. And the businesses are represented by the responsible management board members. For pharma, we have Stefan Oelrich; for Consumer Health, we have Heiko Schipper; and for Crop Science [and everything else], we have Liam Condon. Werner will start off today with an overview of the key developments and performance of the divisions in 2018. Wolfgang will then cover the financials for the fourth quarter and the full year and the outlook 2019, before Werner will close with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
